When it comes to pricing and reimbursement (P&R), what are the trends and technologies that could deliver a better understanding of payers’ needs and build improved evidence of value? Are virtual payer and advisory board meetings really working? Will innovative AI driven tools really identify evidence gaps? When would novel deals such as Novartis’ “Day One Access” and Vertex’s Portfolio models be appropriate?
To identify the latest innovations and thinking in P&R, we interviewed US and European industry experts. In the light of COVID-19 they examine the approaches, technologies and deal structures that are shaping the P&R landscape. Learn from what they said in Innovations in Pricing and Reimbursement.
What to expect
A detailed report revealing expert insights on the innovative approaches and digital technologies that are influencing P&R practice
• An examination of 6 key issues that are impacting P&R strategy and practice
• 12 targeted questions to US and European industry experts
• Their responses which provided 33 insights supported by 97 directly quoted comments